| AG-014699 |
ENSG00000104691.10 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000118412.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000118412.8 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000124915.6 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000135253.9 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000149656.4 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000152931.7 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000153363.8 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000166770.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000172250.10 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000172965.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000175772.10 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000177112.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000177406.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000177738.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000180458.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000180769.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000180769.4 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000180846.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000182021.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000182165.13 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000182310.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000182376.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000182404.6 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000182404.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000185186.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000185203.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000185904.7 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000186056.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000186056.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000186056.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000186148.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000187229.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000188365.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000189223.9 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000196553.9 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000196951.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000197332.7 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000203288.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000203362.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000203364.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000203499.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000203506.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000203801.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000203801.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000203808.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000204011.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000204272.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000204528.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000204581.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000204588.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000204625.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000204666.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000204860.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000205037.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000205488.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000205488.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000206567.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000206567.5 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000212766.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000213793.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000213863.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000213863.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000213963.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000213971.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000214401.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000214401.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000214407.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000214559.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000214559.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000214691.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000214719.7 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000214772.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000215039.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000215068.3 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000215159.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000215417.6 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000215533.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000215692.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000222032.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000222041.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000222043.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000223356.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000223379.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000223380.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000223382.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000223382.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000223390.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000223392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000223393.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000223396.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000223477.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000223525.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000223525.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000223528.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000223552.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000223598.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000223653.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000223675.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000223701.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000223704.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000223768.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000223791.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000223797.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000223839.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000223855.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000223884.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000223942.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000224078.8 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000224081.3 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000224086.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000224138.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000224142.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000224142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000224189.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000224220.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000224269.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000224349.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000224356.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000224358.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000224363.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000224409.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000224441.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000224509.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000224511.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000224621.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000224621.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000224644.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000224652.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000224691.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000224707.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000224738.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000224743.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000224745.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000224745.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000224804.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000224805.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000224846.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000224884.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000224884.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000224897.2 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000224905.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000224959.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000224965.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000224992.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000224992.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000225000.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000225057.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000225077.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000225077.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000225092.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000225111.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000225146.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000225177.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000225195.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000225216.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000225265.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000225269.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000225377.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000225383.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000225479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000225489.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000225518.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000225518.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000225548.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000225767.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000225778.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000225778.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000225953.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000225953.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000225975.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000225975.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000225986.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000226009.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000226047.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000226137.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000226281.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000226291.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000226310.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000226386.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000226455.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000226472.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000226476.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000226476.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000226609.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000226645.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000226648.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000226747.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000226797.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000226800.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000226812.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000226957.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000226963.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000226969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000227039.2 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000227070.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000227197.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000227210.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000227213.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000227214.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000227214.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000227237.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000227245.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000227252.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000227308.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000227372.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000227375.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000227403.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000227407.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000227409.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000227409.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000227456.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000227482.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000227484.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000227542.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000227544.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000227598.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000227603.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000227640.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000227673.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000227674.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000227702.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000227702.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000227719.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000227838.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000227848.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000227848.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000227877.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000227877.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000227885.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000227908.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000227959.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000228044.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000228063.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000228065.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000228084.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000228108.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000228115.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000228137.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000228150.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000228203.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000228223.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000228262.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000228317.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000228386.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000228397.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000228427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000228463.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000228506.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000228509.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000228541.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000228544.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000228544.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000228573.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000228573.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000228613.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000228661.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000228677.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000228679.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000228723.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000228763.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000228775.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000228784.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000228792.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000228794.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000228801.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000228809.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000228817.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000228857.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000228886.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000228917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000229017.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000229118.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000229118.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000229152.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000229178.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000229263.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000229263.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000229368.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000229368.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000229484.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000229487.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000229525.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000229525.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000229587.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000229587.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000229589.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000229628.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000229645.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000229841.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000229848.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000229852.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000229869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000229931.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000229950.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000229955.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000229964.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000229970.3 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000229996.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000230013.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000230021.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000230054.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000230082.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000230148.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000230177.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000230212.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000230257.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000230300.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000230316.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000230319.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000230319.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000230323.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000230337.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000230400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000230423.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000230432.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000230454.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000230499.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000230536.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000230552.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000230561.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000230587.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000230590.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000230628.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000230698.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000230698.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000230736.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000230736.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000230753.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000230826.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000230834.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000230844.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000230925.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000231054.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000231064.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000231074.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000231102.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000231131.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000231172.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000231193.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000231290.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000231298.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000231310.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000231329.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000231367.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000231401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000231412.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000231439.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000231459.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000231473.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000231512.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000231512.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000231521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000231563.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000231599.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000231605.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000231607.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000231651.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000231683.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000231704.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000231729.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000231734.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000231749.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000231760.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000231789.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000231856.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000231858.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000231871.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000231889.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000231889.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000231969.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000232021.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000232021.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000232065.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000232110.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000232131.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000232194.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000232227.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000232233.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000232290.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000232311.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000232352.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000232377.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000232388.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000232401.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000232453.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000232485.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000232527.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000232536.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000232536.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000232600.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000232611.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000232633.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000232684.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000232696.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000232698.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000232712.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000232729.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000232732.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000232754.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000232756.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000232803.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000232855.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000232907.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000232912.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000232973.7 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000232977.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000232977.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000233033.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000233081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000233101.6 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000233101.6 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000233137.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000233184.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000233223.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000233296.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000233321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000233396.3 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000233411.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000233452.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000233491.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000233501.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000233509.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000233554.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000233559.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000233661.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000233684.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000233694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000233785.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000233834.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000233844.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000233885.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000233895.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000233906.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000233912.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000233981.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000234019.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000234129.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000234141.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000234171.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000234171.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000234185.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000234197.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000234225.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000234229.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000234263.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000234350.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000234389.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000234393.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000234396.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000234494.3 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000234509.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000234571.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000234622.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000234663.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000234695.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000234705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000234793.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000234871.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000234913.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000234936.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000234997.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000234998.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000235005.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000235021.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000235029.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000235042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000235079.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000235100.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000235146.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000235146.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000235180.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000235244.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000235246.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000235271.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000235427.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000235481.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000235501.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000235586.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000235609.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000235609.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000235706.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000235706.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000235724.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000235726.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000235741.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000235770.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000235790.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000235806.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000235820.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000235837.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000235903.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000235979.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000235999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000236016.3 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000236088.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000236094.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000236140.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000236199.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000236199.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000236204.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000236204.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000236242.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000236256.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000236268.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000236269.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000236345.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000236383.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000236385.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000236449.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000236471.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000236472.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000236559.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000236601.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000236627.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000236682.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000236711.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000236753.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000236778.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000236824.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000236914.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000236915.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000236935.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000236943.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000236943.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000237073.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000237133.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000237181.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000237248.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000237380.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000237390.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000237399.3 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000237438.2 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000237476.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000237517.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000237520.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000237520.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000237525.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000237594.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000237613.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000237737.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000237737.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000237756.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000237803.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000237813.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000237819.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000237845.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000237877.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000237877.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000237877.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000237927.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000237927.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000237943.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000237943.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000237945.3 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000237998.3 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000238005.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000238099.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000238121.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000238122.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000238123.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000238123.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000238197.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000238210.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000238272.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000239300.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000239407.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000239480.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000239552.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000239664.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000239705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000239828.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000239941.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000240005.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000240015.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000240207.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000240207.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000240241.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000240449.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000240449.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000240453.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000240497.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000240541.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000240553.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000240915.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000241220.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000241280.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000241544.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000241732.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000241732.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000241954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000241954.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000242104.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000242104.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000242125.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000242258.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000242474.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000242797.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000242797.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000242798.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000242798.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000243176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000243193.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000243220.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000243368.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000243433.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000243485.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000243533.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000243629.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000243637.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000243849.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000243885.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000243902.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000244184.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000244203.2 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000244268.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000244300.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000244349.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000244513.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000244513.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000244625.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000244649.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000244675.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000244757.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000244926.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000244945.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000244952.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000245112.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000245213.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000245275.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000245281.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000245293.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000245322.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000245522.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000245552.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000245694.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000245729.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000245750.3 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000245857.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000245910.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000246016.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000246067.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000246089.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000246090.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000246090.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000246145.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000246263.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000246273.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000246740.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000246763.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000246982.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000246982.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000247137.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000247317.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000247400.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000247416.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000247735.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000247796.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000247828.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000247877.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000248019.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000248115.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000248161.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000248161.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000248175.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000248223.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000248256.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000248256.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000248268.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000248476.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000248508.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000248533.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000248664.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000248714.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000248719.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000248734.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000248734.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000248734.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000248790.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000248968.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000249028.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000249085.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000249116.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000249159.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000249207.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000249258.2 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000249328.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000249348.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000249359.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000249375.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000249379.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000249417.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000249500.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000249602.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000249635.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000249650.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000249655.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000249664.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000249664.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000249700.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000249706.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000249849.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000249849.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000249870.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000249898.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000249942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000250012.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000250012.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000250033.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000250039.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000250041.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000250061.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000250116.2 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000250122.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000250129.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000250131.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000250267.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000250312.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000250404.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000250508.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000250509.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000250614.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000250614.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000250629.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000250734.2 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000250751.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000250764.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000250786.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000250842.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000250903.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000250934.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000250999.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000250999.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000251023.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000251023.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000251027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000251131.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000251148.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000251148.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000251179.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000251298.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000251307.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000251314.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000251350.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000251364.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000251365.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000251405.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000251432.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000251432.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000251432.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000251432.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000251523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000251580.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000251603.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000251613.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000251615.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000251629.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000251637.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000251666.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000251867.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000253121.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000253133.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000253167.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000253210.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000253282.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000253284.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000253302.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000253317.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000253361.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000253374.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000253390.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000253404.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000253476.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000253490.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000253526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000253582.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000253666.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000253696.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000253708.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000253736.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000253824.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000253858.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000253859.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000253917.3 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000253921.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000253973.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000253982.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000254084.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000254084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000254154.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000254281.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000254281.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000254286.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000254288.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000254315.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000254333.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000254338.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000254362.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000254397.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000254432.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000254444.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000254477.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000254528.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000254530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000254551.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000254615.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000254620.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000254638.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000254662.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000254664.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000254671.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000254694.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000254739.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000254812.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000254814.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000254837.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000254860.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000254885.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000254887.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000254907.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000254911.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000254977.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000255020.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000255029.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000255050.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000255100.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000255119.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000255145.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000255145.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000255148.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000255158.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000255159.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000255160.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000255241.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000255247.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000255247.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000255248.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000255320.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000255328.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000255343.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000255343.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000255348.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000255348.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000255409.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000255428.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000255435.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000255435.2 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000255462.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000255503.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000255539.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000255621.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000255760.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000255867.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000255886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000255989.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000255989.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000255992.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000256020.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000256139.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000256139.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000256150.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000256196.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000256209.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000256226.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000256271.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000256381.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000256433.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000256433.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000256442.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000256609.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000256705.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000256789.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000256802.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000256811.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000256973.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000256982.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000257002.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000257004.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000257027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000257086.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000257151.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000257221.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000257226.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000257261.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000257270.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000257298.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000257337.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000257345.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000257433.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000257449.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000257496.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000257497.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000257497.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000257499.2 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000257507.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000257530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000257534.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000257557.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000257588.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000257702.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000257718.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000257735.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000257769.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000257809.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000257859.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000257859.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000257894.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000257910.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000257925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000258034.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000258082.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000258082.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000258086.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000258088.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000258096.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000258096.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000258099.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000258172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000258181.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000258302.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000258317.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000258378.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000258402.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000258450.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000258454.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000258454.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000258458.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000258471.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000258486.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000258520.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000258526.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000258534.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000258548.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000258553.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000258561.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000258593.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000258623.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000258623.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000258676.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000258733.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000258789.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000258791.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000258809.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000258811.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000258813.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000258813.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000258824.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000258825.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000258858.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000258871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000258902.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000258914.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000258940.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000258946.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000258999.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000259005.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000259038.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000259039.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000259054.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000259062.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000259065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000259083.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000259116.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000259135.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000259138.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000259146.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000259188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000259198.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000259209.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000259209.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000259222.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000259244.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000259250.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000259265.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000259275.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000259287.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000259298.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000259310.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000259322.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000259336.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000259343.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000259345.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000259366.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000259366.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000259366.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000259366.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000259380.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000259402.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000259407.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000259408.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000259416.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000259417.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000259426.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000259438.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000259447.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000259456.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000259499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000259504.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000259514.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000259520.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000259521.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000259521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000259542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000259553.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000259579.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000259583.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000259584.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000259594.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000259663.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000259673.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000259705.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000259755.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000259768.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000259772.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000259783.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000259797.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000259871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000259886.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000259894.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000259894.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000259899.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000259901.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000259915.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000259915.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000259953.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000259953.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000259964.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000260000.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000260006.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000260017.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000260018.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000260021.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000260038.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000260060.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000260088.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000260131.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000260141.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000260160.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000260167.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000260173.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000260185.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000260193.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000260196.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000260236.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000260257.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000260273.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000260273.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000260278.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000260296.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000260310.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000260316.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000260328.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000260331.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000260349.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000260381.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000260388.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000260388.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000260404.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000260411.2 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000260468.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000260498.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000260558.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000260577.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000260579.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000260583.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000260583.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000260588.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000260608.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000260633.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000260635.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000260645.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000260648.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000260651.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000260651.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000260664.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000260698.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000260733.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000260766.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000260807.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000260814.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000260830.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000260833.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000260874.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000260891.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000260917.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000260948.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000260978.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000260979.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000260992.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000261015.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000261055.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000261083.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000261092.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000261096.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000261096.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000261124.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000261131.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000261140.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000261140.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000261167.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000261183.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000261183.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000261183.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000261187.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000261207.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000261211.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000261218.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000261220.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000261235.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000261254.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000261266.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000261280.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000261326.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000261373.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000261374.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000261416.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000261431.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000261438.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000261471.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000261476.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000261485.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000261513.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000261519.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000261529.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000261534.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000261534.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000261542.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000261550.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000261616.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000261633.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000261654.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000261670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000261692.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000261736.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000261760.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000261765.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000261775.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000261801.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000261824.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000261839.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000261924.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000261925.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000261996.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000262115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000262119.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000262136.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000262171.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000262172.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000262228.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000262319.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000262514.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000262652.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000262686.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000262703.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000262745.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000262873.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000262881.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000262888.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000263013.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000263120.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000263300.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000263316.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000263345.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000263370.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000263388.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000263466.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000263612.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000263718.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000263884.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000263893.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000263931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000264007.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000264083.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000264107.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000264196.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000264196.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000264247.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000264270.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000264513.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000264635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000264666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000264745.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000264745.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000264745.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000264829.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000264885.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000264932.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000264932.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000264940.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000264968.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000265094.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000265206.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000265206.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000265218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000265242.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000265334.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000265337.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000265349.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000265394.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000265451.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000265479.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000265490.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000265519.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000265542.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000265692.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000265692.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000265728.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000265749.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000265752.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000265845.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000265888.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000265912.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000265943.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000265992.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000266111.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000266289.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000266340.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000266401.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000266402.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000266411.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000266456.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000266538.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000266541.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000266598.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000266644.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000266805.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000266805.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000266821.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000266824.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000266904.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000266918.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000266918.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000266921.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000266930.2 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000266933.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000266973.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000266975.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000266976.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000266987.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000266987.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000266993.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000266993.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000267010.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000267010.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000267016.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000267040.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000267073.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000267104.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000267117.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000267141.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000267141.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000267141.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000267143.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000267150.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000267191.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000267193.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000267198.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000267199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000267213.3 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000267219.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000267221.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000267255.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000267259.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000267263.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000267288.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000267299.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000267302.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000267313.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000267342.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000267373.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000267374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000267374.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000267383.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000267395.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000267412.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000267424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000267432.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000267457.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000267470.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000267474.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000267476.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000267476.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000267479.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000267493.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000267501.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000267501.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000267505.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000267519.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000267522.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000267568.2 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000267581.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000267582.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000267582.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000267588.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000267637.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000267667.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000267701.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000267702.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000267705.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000267737.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000267737.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000267750.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000267764.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000267776.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000267778.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000267787.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000267804.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000267868.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000267871.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000267871.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000267919.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000267934.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000267940.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000268001.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000268051.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000268186.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000268199.2 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000268230.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000268262.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000268266.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000268340.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000268499.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000268573.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000268613.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000268743.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000268895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000268912.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000268912.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000268913.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000268947.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000268970.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000269051.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000269066.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000269102.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000269107.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000269220.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000269289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000269392.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000269397.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000269425.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000269439.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000269534.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000269560.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000269653.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000269653.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000269696.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000269696.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000269806.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000269825.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000269834.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000269842.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000269893.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000269893.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000269896.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000269923.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000269944.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000269946.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000269947.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000269951.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000269956.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000269959.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000269961.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000269973.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000269976.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000269978.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000269979.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000269985.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000270000.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000270010.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000270012.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000270019.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000270020.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000270068.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000270084.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000270095.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000270095.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000270117.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000270133.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000270141.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000270159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000270170.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000270174.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000270190.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000270210.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000270223.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000270344.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000270346.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000270426.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000270523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000270604.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000270604.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000270604.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000270605.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000270607.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000270640.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000270659.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000270659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000270661.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000270704.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000270720.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000270760.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000270964.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000271032.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000271119.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000271172.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000271204.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000271218.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000271359.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000271366.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| AG-014699 |
ENSG00000271401.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000271538.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000271576.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000271584.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000271590.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000271590.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000271716.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000271717.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000271722.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000271722.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000271738.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000271743.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000271755.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000271757.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000271789.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000271815.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000271825.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000271825.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000271825.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000271840.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000271843.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000271849.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000271856.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000271869.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000271869.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000271889.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000271914.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000271926.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000271963.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000271963.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000271964.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000271967.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000271975.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000271991.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000271992.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000272002.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000272005.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000272009.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000272023.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000272030.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000272033.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000272040.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000272049.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000272086.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000272087.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000272091.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000272092.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000272093.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000272097.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000272102.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000272129.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000272129.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000272137.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000272143.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000272144.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000272146.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000272158.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000272158.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000272211.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000272217.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000272217.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000272288.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000272298.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000272361.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000272365.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000272369.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000272369.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000272373.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000272417.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000272417.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000272420.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000272463.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000272465.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000272468.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000272489.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000272498.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000272512.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000272516.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000272524.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000272554.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000272567.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000272574.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000272609.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000272627.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000272650.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000272668.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000272682.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000272682.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000272689.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000272691.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000272691.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000272715.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000272719.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000272720.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000272744.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000272755.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000272763.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000272769.1 |
Predicted lncRNA |
Sarcoma |
|
| AG-014699 |
ENSG00000272787.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000272792.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000272796.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000272799.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| AG-014699 |
ENSG00000272810.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000272828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000272848.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000272861.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000272870.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000272871.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000272888.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000272902.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000272911.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000272913.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000272915.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000272917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000272931.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000272933.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000272942.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000272970.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000272975.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000272979.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000272983.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000272989.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000272992.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000273001.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000273004.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000273011.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000273027.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000273038.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000273081.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000273091.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000273091.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000273125.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| AG-014699 |
ENSG00000273160.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000273188.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000273213.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000273232.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000273232.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000273240.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000273297.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
ENSG00000273305.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| AG-014699 |
ENSG00000273311.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| AG-014699 |
ENSG00000273311.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| AG-014699 |
ENSG00000273344.1 |
Predicted lncRNA |
Esophageal cancer |
|
| AG-014699 |
ENSG00000273350.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| AG-014699 |
ENSG00000273366.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| AG-014699 |
ENSG00000273373.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000273402.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| AG-014699 |
ENSG00000273449.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000273472.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| AG-014699 |
ENSG00000273472.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| AG-014699 |
ENSG00000273476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| AG-014699 |
miR-9 |
Curated miRNA |
ovarian cancer |
|
